IL6 and breast carcinoma: In addition, TAMs secrete high levels of IL-6 increasing stemness markers (i.e. SOX2, OCT3/4 and NANOG) and consequently CSCs expansion in breast cancer cells via STAT3 pathway supporting tumor cells migration and angiogenesis (125).